Latest Seek News

Decidr AI Industries delivered 99% revenue growth and a A$13.6 million annualised exit rate in FY26, but the company’s A$32.4 million loss and auditor-highlighted going concern uncertainty put funding at the centre of its next chapter. Management is targeting A$5 million in annualised savings while seeking to convert early AI deployments into recurring revenue.

Rimfire Pacific Mining has expanded its NSW scandium inventory and reported preliminary leach results that could support a simpler extraction route. But the ASX explorer ended FY2026 with $583,770 in cash, negative working capital and an auditor-highlighted material uncertainty over its ability to continue as a going concern.

Botala Energy’s Serowe CBM project has reached its most important testing phase after well 3.5B delivered strong early water production and casing pressure. The operational progress is material, but the company still faces a funding hurdle and has not yet demonstrated sustained commercial gas flow.

HiTech Group Australia delivered a weaker FY2026 profit and lower revenue, but finished with $10.56 million in cash and no debt before completing its Hudson acquisition. The post-year-end deal and $4 million institutional raise now place execution, funding and integration at the centre of the story.

Reedy Lagoon is relying on shareholder approval for a $1.8 million underwritten placement after ending the year with $44,416 in cash and a material uncertainty over its ability to continue as a going concern. The recapitalisation would fund exploration, but comes with substantial dilution and a staged repayment of related-party debt.

MRG Metals has reported exceptional rare earth grades at its newly acquired Garies project and advanced its Mozambique portfolio, but the explorer remains dependent on capital markets. The FY26 annual report flags material uncertainty over going concern despite a subsequent A$725,000 placement and a further share purchase plan.

Vection Technologies delivered its first positive full-year operating cash flow and a sharp rise in adjusted EBITDA in FY26. Yet the audited report warns that continued operations depend on stronger sales, margin gains, cost reductions and potential access to further capital.

Imagion Biosystems has secured central ethics approval for its US Phase 1b/2 trial of the MagSense HER2 imaging agent, removing a key requirement before recruitment can begin. Site activation is now underway, but no patient has yet been enrolled and the announcement provides no clinical data.

Accelerate Resources enters FY2027 with high-grade manganese targets at Woodie Woodie North and new gold zones at Balagundi, but a sharp annual loss and ongoing funding needs remain part of the story. The company plans maiden and follow-up drilling while seeking shareholder approval to rename itself Mango Metals.

Vectus Biosystems has secured a pre-IND Type B meeting with the FDA for its lead IPF drug candidate VB0004. The regulator’s written feedback, expected by mid-November, should clarify the next US development steps but does not yet authorise clinical trials.

Yugo Metals finished 2026 with A$6.29 million in cash after raising A$8.6 million, giving its Bosnia and Herzegovina exploration program more financial room. The trade-off was a net loss of A$3.93 million, more than double the previous year, alongside substantial equity issuance and ongoing funding risk.

European Metals will temporarily lose 6.38 percentage points of its Geomet stake after CEZ agreed to fund a EUR13 million cash call. The company intends to buy back the interest for EUR6.448 million, but must first secure financing by 13 November 2026.